SCHEMBL30752633

SCHEMBL30752633

CN(CCO[Si](C)(C)C(C)(C)C)c1nc(Cl)nc2c(F)c(Br)c(C(F)(F)F)cc12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30752592 0.84 — —
SCHEMBL30752602 0.81 PDE2A (0.34) —
SCHEMBL30752563 0.78 — —
SCHEMBL30752591 0.77 — —
SCHEMBL30752575 0.76 — —
SCHEMBL30752593 0.76 — —
SCHEMBL30752565 0.75 — —
SCHEMBL30752568 0.75 — —
SCHEMBL30752566 0.75 — —
SCHEMBL30752579 0.70 AR (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565579-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF KRAS Theras, Inc. (US) 2025-06-11 — — EP disclosed
Send feedback